Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model.
BACKGROUND
Little is known about the effects of heart failure (HF) on the defibrillation threshold (DFT) and the characteristics of activation during ventricular fibrillation (VF).


RESULTS
HF was induced by rapid right ventricular (RV) pacing for at least 3 weeks in 6 dogs. Another 6 dogs served as controls. Catheter defibrillation electrodes were placed in the RV apex, the superior vena cava, and the great cardiac vein (CV). An active can coupled to the superior vena cava electrode served as the return for the RV and CV electrodes. DFTs were determined before and during HF for a shock through the RV electrode with and without a smaller auxiliary shock through the CV electrode. VF activation patterns were recorded in HF and control animals from 21x24 unipolar electrodes spaced 2 mm apart on the ventricular epicardium. Using these recordings, we computed a number of quantitative VF descriptors. DFT was unchanged in the control dogs. DFT energy was increased 79% and 180% (with and without auxiliary shock, respectively) in HF compared with control dogs. During but not before HF, DFT energy was significantly lowered (21%) by addition of the auxiliary shock. The VF descriptors revealed marked VF differences between HF and control dogs. The differences suggest decreased excitability and an increased refractory period during HF. Most, but not all, descriptors indicate that VF was less complex during HF, suggesting that VF complexity is multifactorial and cannot be expressed by a scalar quantity.


CONCLUSIONS
HF increases the DFT. This is partially reversed by an auxiliary shock. HF markedly changes VF activation patterns.
Department of Medicine, University of Alabama at Birmingham, USA.
J
J
Huang
J M
JM
Rogers
C R
CR
Killingsworth
G P
GP
Walcott
B H
BH
KenKnight
W M
WM
Smith
R E
RE
Ideker
D000704:Analysis of Variance; D000818:Animals; D001794:Blood Pressure; D002304:Cardiac Pacing, Artificial / Q000009:adverse effects; D004195:Disease Models, Animal; D004285:Dogs; D004554:Electric Countershock; D006331:Heart Diseases / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000503:physiopathology*